Physician profile
William Cox
NPI 1952353153
$605.08
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $31.62 · 2022: $18.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $147.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $99.68 | 2019 | |
| Astellas Pharma US INC | $78.92 | 2019-2020 | |
| Pfizer INC. | $69.20 | 2019 | |
| Amgen INC. | $66.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.42 | 2019 | |
| Inari Medical, INC. | $18.50 | 2022 | |
| Allergan, INC. | $15.70 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.11 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.84 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.50 | 2019 | |
| Akcea Therapeutics, INC. | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.